GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Centene Corp (NYSE:CNC) » Definitions » Capex-to-Operating-Cash-Flow

Centene (Centene) Capex-to-Operating-Cash-Flow : 1.03 (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Centene Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Centene's Capital Expenditure for the three months ended in Dec. 2023 was $-223.00 Mil. Its Cash Flow from Operations for the three months ended in Dec. 2023 was $217.00 Mil.

Hence, Centene's Capex-to-Operating-Cash-Flow for the three months ended in Dec. 2023 was 1.03.


Centene Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Centene's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centene Capex-to-Operating-Cash-Flow Chart

Centene Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.49 0.16 0.22 0.16 0.10

Centene Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.05 0.08 0.13 1.03

Competitive Comparison of Centene's Capex-to-Operating-Cash-Flow

For the Healthcare Plans subindustry, Centene's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Centene's Capex-to-Operating-Cash-Flow Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Centene's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Centene's Capex-to-Operating-Cash-Flow falls into.



Centene Capex-to-Operating-Cash-Flow Calculation

Centene's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-799) / 8053
=0.10

Centene's Capex-to-Operating-Cash-Flow for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-223) / 217
=1.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Centene  (NYSE:CNC) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Centene Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Centene's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Centene (Centene) Business Description

Industry
Address
7700 Forsyth Boulevard, Centene Plaza, St. Louis, MO, USA, 63105
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.
Executives
Lori Jean Robinson director 5875 LANDERBROOK DRIVE, SUITE 220, CLEVELAND OH 44124
Andrew Lynn Asher officer: EVP, CFO 8735 HENDERSON ROAD, TAMPA FL 33634
James E Murray officer: EVP, Chief Transform. Officer 500 WEST MAIN STREET, LOUISVILLE KY 40202
Samuels Theodore R. Ii director 1990 E. GRAND AVE., EL SEGUNDO CA 90245
Monte E Ford director C/O AKAMAI TECHNOLOGIES, INC., 8 CAMBRIDGE CENTER, CAMBRIDGE MA 02142
Kenneth J Fasola officer: EVP, Health Care Enterprises 500 WEST MAIN STREET, LOUISVILLE KY 40202
Shannon Bagley officer: EVP, Chief Admin. Officer 7700 FORSYTH BOULEVARD, CLAYTON MO 63105
Richard A Gephardt director 822 CAPITOL SQUARE PLACE, SW, WASHINGTON DC 20024
Christopher J Coughlin director
H James Dallas director 127 PUBLIC SQUARE, CLEVELAND OH 44114
Mark J Brooks officer: SVP, Chief Information Officer 7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
David P Thomas officer: EVP, MARKETS 7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
Leslie V Norwalk director C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130
Wayne S Deveydt director 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Toney Colin A officer: EVP, Mergers & Acquisitions 7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105

Centene (Centene) Headlines

From GuruFocus

Q4 2022 Centene Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Centene Corp at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-22-2024

Centene Corp Annual Shareholders Meeting Transcript

By GuruFocus Research 01-22-2024

Q3 2022 Centene Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2023 Centene Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Centene Corp at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-22-2024

Q1 2023 Centene Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024